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Lymphocyte transformation test (LTT) is a widely used
assay to detect drug-specific T cell reaction, but its rela-
tively low sensitivity renders risk for pseudo-negativity.
Basophil activation test (BAT) is an emerging assay initi-
ally used to diagnose food allergy, but its application to
drug hypersensitivity as been reported anecdotally.
Although a promising assay, the clinical settings or a parti-
cular class of drugs in which BAT is useful has not been
well characterized. Herein, we performed a side-by-side
comparison of BAT and LTT in detecting culprit drugs in
several types of drug hypersensitivities. 248 patients who
visited our department from October 2011 to December
2013 were enrolled in this study. Peripheral blood cells
drawn from patients were co-cultured with or without
relevant drugs. LTT was performed according to a stan-
dard protocol with 3H-thymidine uptake and stimulation
index of 1.8 and above (CPM value with drug divided by
CPM without drug) were defined positive. For BAT, whole
blood cells were exposed to drugs for 24hrs and were
assessed via flow cytometry for the proportion of cells that
had upregulated CD203c (activated state) among total
basophils. 9.0% and above were defined positive, based on
values from healthy controls (mean value + 5SD). Overall,
14.7% and 28.8% of culprit drugs tested yielded positive
results by BAT and LTT, respectively. Analysis of disease
phenotype of patients revealed that BAT yielded positive
results not only in immediate-type, but also delayed-type
hypersensitivity such as drug-induced hypersensitivity syn-
drome and Stevens-Johnson syndrome. Of note, samples
that yielded positive for LTT and BAT did not overlap,
suggesting that the two analyses might compensate each
other for pseudo-negativity. Furthermore, analysis focusing
on the class of antibiotics showed that macrolides were
frequently obtained positive via BAT, whereas that for
-lactams tended to be positive via LTT. Utilizing both
BAT and LTT, we screened antibiotics and NSAIDs for
selection of drugs that could be used for challenge tests in
patients with histories of multiple drug allergy. The nega-
tive indicative value was 96.4%, suggesting the usefulness
of these assays in safely identifying drugs for future use.
Taken together, different spectrum of drugs can be
covered by performing both BAT and LTT, allowing iden-
tification of culprit drugs with higher sensitivity than by
performing a single assay.
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